Trexquant Investment’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,899
| Closed | -$453K | – | 1510 |
|
|
2024
Q2 | $453K | Sell |
17,899
-18,902
| -51% | -$479K | 0.01% | 1276 |
|
|
2024
Q1 | $935K | Sell |
36,801
-21,662
| -37% | -$550K | 0.02% | 938 |
|
|
2023
Q4 | $1.32M | Buy |
58,463
+7,811
| +15% | +$177K | 0.03% | 718 |
|
|
2023
Q3 | $944K | Buy |
+50,652
| New | +$944K | 0.02% | 777 |
|
|
2023
Q1 | – | Sell |
-26,677
| Closed | -$790K | – | 1417 |
|
|
2022
Q4 | $790K | Buy |
26,677
+11,485
| +76% | +$340K | 0.02% | 738 |
|
|
2022
Q3 | $362K | Sell |
15,192
-5,966
| -28% | -$142K | 0.01% | 942 |
|
|
2022
Q2 | $472K | Buy |
21,158
+5,548
| +36% | +$124K | 0.02% | 856 |
|
|
2022
Q1 | $392K | Buy |
+15,610
| New | +$392K | 0.02% | 880 |
|
|
2021
Q3 | – | Sell |
-5,006
| Closed | -$217K | – | 1106 |
|
|
2021
Q2 | $217K | Buy |
+5,006
| New | +$217K | 0.02% | 871 |
|
|
2020
Q1 | – | Sell |
-10,283
| Closed | -$533K | – | 1077 |
|
|
2019
Q4 | $533K | Buy |
10,283
+4,463
| +77% | +$231K | 0.03% | 541 |
|
|
2019
Q3 | $319K | Buy |
+5,820
| New | +$319K | 0.03% | 598 |
|
|
2019
Q2 | – | Sell |
-11,820
| Closed | -$357K | – | 784 |
|
|
2019
Q1 | $357K | Buy |
+11,820
| New | +$357K | 0.03% | 683 |
|
|
2018
Q4 | – | Sell |
-5,403
| Closed | -$228K | – | 1016 |
|
|
2018
Q3 | $228K | Buy |
+5,403
| New | +$228K | 0.02% | 781 |
|
|
2017
Q2 | – | Sell |
-12,807
| Closed | -$556K | – | 776 |
|
|
2017
Q1 | $556K | Buy |
+12,807
| New | +$556K | 0.07% | 490 |
|
|
2015
Q4 | – | Sell |
-8,900
| Closed | -$283K | – | 989 |
|
|
2015
Q3 | $283K | Buy |
+8,900
| New | +$283K | 0.02% | 888 |
|
|
2015
Q1 | – | Sell |
-10,919
| Closed | -$444K | – | 973 |
|
|
2014
Q4 | $444K | Buy |
+10,919
| New | +$444K | 0.08% | 512 |
|